Question

A 64-year-old man with new nonvalvular atrial fibrillation (CHA₂DS₂-VASc = 2; no significant valvular disease, normal renal function) needs stroke prevention. Which is preferred?

Accepted Answer

Apixaban

Answer

Warfarin (target INR 2-3)

Answer

Aspirin

Answer

No antithrombotic therapy

Answer

Clopidogrel monotherapy

Practice question

A 64-year-old man with new nonvalvular atrial fibrillation (CHA₂DS₂-VASc = 2; no significant valvular disease, normal renal function) needs stroke prevention. Which is preferred?